643 related articles for article (PubMed ID: 26484606)
21. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
22. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
23. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
[TBL] [Abstract][Full Text] [Related]
24. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
[TBL] [Abstract][Full Text] [Related]
25. [In vivo short hairpin RNA interference of vascular endothelial growth factor on drug-resistant tongue cancer cells].
Nong XL; Li H; Xia Y; Li Y; Li JQ; Yang YP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jan; 46(1):15-9. PubMed ID: 21418939
[TBL] [Abstract][Full Text] [Related]
26. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B
Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445
[TBL] [Abstract][Full Text] [Related]
27. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
28. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
29. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
30. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
Sun P; Yu H; Zhang WQ; Hu M; Lv R
Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
[TBL] [Abstract][Full Text] [Related]
31. Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus.
Matsuki M; Adachi Y; Ozawa Y; Kimura T; Hoshi T; Okamoto K; Tohyama O; Mitsuhashi K; Yamaguchi A; Matsui J; Funahashi Y
Cancer Sci; 2017 Apr; 108(4):763-771. PubMed ID: 28107584
[TBL] [Abstract][Full Text] [Related]
32. Ursolic acid-downregulated long noncoding RNA ASMTL-AS1 inhibits renal cell carcinoma growth via binding to HuR and reducing vascular endothelial growth factor expression.
Cai C; Zhi Y; Xie C; Geng S; Sun F; Ji Z; Zhang P; Wang H; Tang J
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23389. PubMed ID: 37300450
[TBL] [Abstract][Full Text] [Related]
33. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
[TBL] [Abstract][Full Text] [Related]
34. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
[TBL] [Abstract][Full Text] [Related]
35. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
Fan YZ; Chen CQ; Zhao ZM; Sun W
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
[TBL] [Abstract][Full Text] [Related]
36. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
[TBL] [Abstract][Full Text] [Related]
37. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
[TBL] [Abstract][Full Text] [Related]
38. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
[TBL] [Abstract][Full Text] [Related]
39. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
40. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]